Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study.
Kirchheiner K, Smet S, Jürgenliemk-Schulz IM, Haie-Meder C, Chargari C, Lindegaard JC, Fokdal LU, Spampinato S, Schmid MP, Sturdza A, Mahantshetty U, Segedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Sundset M, van Limbergen E, Villafranca E, Westerveld H, Tan LT, Pötter R, Tanderup K, Nout RA; EMBRACE Collaborative Group. Kirchheiner K, et al. Among authors: westerveld h. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):400-413. doi: 10.1016/j.ijrobp.2021.08.036. Epub 2021 Sep 1. Int J Radiat Oncol Biol Phys. 2022. PMID: 34478833
Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, Petrič P, Mahantshetty U, Dörr W, Pötter R. Kirchheiner K, et al. Among authors: westerveld h. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):88-95. doi: 10.1016/j.ijrobp.2014.01.032. Int J Radiat Oncol Biol Phys. 2014. PMID: 24725693
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
Wortman BG, Bosse T, Nout RA, Lutgens LCHW, van der Steen-Banasik EM, Westerveld H, van den Berg H, Slot A, De Winter KAJ, Verhoeven-Adema KW, Smit VTHBM, Creutzberg CL; PORTEC Study Group. Wortman BG, et al. Among authors: westerveld h. Gynecol Oncol. 2018 Oct;151(1):69-75. doi: 10.1016/j.ygyno.2018.07.020. Epub 2018 Aug 3. Gynecol Oncol. 2018. PMID: 30078506 Free article. Clinical Trial.
Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.
Schmid MP, Fokdal L, Westerveld H, Chargari C, Rohl L, Morice P, Nesvacil N, Mazeron R, Haie-Meder C, Pötter R, Nout RA; GEC-ESTRO GYN Working Group. Schmid MP, et al. Among authors: westerveld h. Radiother Oncol. 2020 Apr;145:36-44. doi: 10.1016/j.radonc.2019.11.005. Epub 2019 Dec 23. Radiother Oncol. 2020. PMID: 31874348
69 results